121 related articles for article (PubMed ID: 9070306)
21. Synthesis, in vivo evaluation and PET study of a carbon-11-labeled neuronal nitric oxide synthase (nNOS) inhibitor S-methyl-L-thiocitrulline.
Zhang J; Xu M; Dence CS; Sherman EL; McCarthy TJ; Welch MJ
J Nucl Med; 1997 Aug; 38(8):1273-8. PubMed ID: 9255165
[TBL] [Abstract][Full Text] [Related]
22. Acetyl-L-carnitine.
Altern Med Rev; 1999 Dec; 4(6):438-41. PubMed ID: 10608918
[TBL] [Abstract][Full Text] [Related]
23. Brain serotonin synthesis rates in rhesus monkeys determined by [11C]alpha-methyl-L-tryptophan and positron emission tomography compared to CSF 5-hydroxyindole-3-acetic acid concentrations.
Shoaf SE; Carson R; Hommer D; Williams W; Higley JD; Schmall B; Herscovitch P; Eckelman W; Linnoila M
Neuropsychopharmacology; 1998 Nov; 19(5):345-53. PubMed ID: 9778657
[TBL] [Abstract][Full Text] [Related]
24. Automated chemoenzymatic synthesis of no-carrier-added [carbonyl-11C]propionyl L-carnitine for pharmacokinetic studies.
Davenport RJ; Pike VW; Dowsett K; Turton DR; Poole K
Appl Radiat Isot; 1997 Jul; 48(7):917-24. PubMed ID: 9376826
[TBL] [Abstract][Full Text] [Related]
25. Attenuation by acetyl-L-carnitine of neurological damage and biochemical derangement following brain ischemia and reperfusion.
Calvani M; Arrigoni-Martelli E
Int J Tissue React; 1999; 21(1):1-6. PubMed ID: 10463134
[TBL] [Abstract][Full Text] [Related]
26. A comparison of 11C-labeled L-DOPA and L-fluorodopa as positron emission tomography tracers for the presynaptic dopaminergic system.
Torstenson R; Tedroff J; Hartvig P; Fasth KJ; Långström B
J Cereb Blood Flow Metab; 1999 Oct; 19(10):1142-9. PubMed ID: 10532639
[TBL] [Abstract][Full Text] [Related]
27. Changes in hepatic lipogenic and oxidative enzymes and glucose homeostasis induced by an acetyl-L-carnitine and nicotinamide treatment in dyslipidaemic insulin-resistant rats.
Ferreira MR; Camberos Mdel C; Selenscig D; Martucci LC; Chicco A; Lombardo YB; Cresto JC
Clin Exp Pharmacol Physiol; 2013 Mar; 40(3):205-11. PubMed ID: 23278446
[TBL] [Abstract][Full Text] [Related]
28. Disposition of L-carnitine and its short-chain esters, acetyl-L-carnitine and propionyl-L-carnitine, in the rat isolated perfused liver.
Mancinelli A; Longo A; Nation RL; Evans AM
Drug Metab Dispos; 2000 Dec; 28(12):1401-4. PubMed ID: 11095575
[No Abstract] [Full Text] [Related]
29. L-Carnitine and Acetyl-L-carnitine Roles and Neuroprotection in Developing Brain.
Ferreira GC; McKenna MC
Neurochem Res; 2017 Jun; 42(6):1661-1675. PubMed ID: 28508995
[TBL] [Abstract][Full Text] [Related]
30. Intravenous L-carnitine and acetyl-L-carnitine in medium-chain acyl-coenzyme A dehydrogenase deficiency and isovaleric acidemia.
Van Hove JL; Kahler SG; Millington DS; Roe DS; Chace DH; Heales SJ; Roe CR
Pediatr Res; 1994 Jan; 35(1):96-101. PubMed ID: 8134205
[TBL] [Abstract][Full Text] [Related]
31. Uptake of L-carnitine, D-carnitine and acetyl-L-carnitine by isolated guinea-pig enterocytes.
Gross CJ; Henderson LM; Savaiano DA
Biochim Biophys Acta; 1986 May; 886(3):425-33. PubMed ID: 3708005
[TBL] [Abstract][Full Text] [Related]
32. Metabolism and disposition of intravenously administered acetyl-L-carnitine in healthy volunteers.
Marzo A; Arrigoni Martelli E; Urso R; Rocchetti M; Rizza V; Kelly JG
Eur J Clin Pharmacol; 1989; 37(1):59-63. PubMed ID: 2591464
[TBL] [Abstract][Full Text] [Related]
33. Regulation of fatty acid oxidation by acetyl-CoA generated from glucose utilization in isolated myocytes.
Abdel-aleem S; Nada MA; Sayed-Ahmed M; Hendrickson SC; St Louis J; Walthall HP; Lowe JE
J Mol Cell Cardiol; 1996 May; 28(5):825-33. PubMed ID: 8762022
[TBL] [Abstract][Full Text] [Related]
34. Long-term ethanol administration enhances age-dependent modulation of redox state in different brain regions in the rat: protection by acetyl carnitine.
Calabrese V; Scapagnini G; Latteri S; Colombrita C; Ravagna A; Catalano C; Pennisi G; Calvani M; Butterfield DA
Int J Tissue React; 2002; 24(3):97-104. PubMed ID: 12635862
[TBL] [Abstract][Full Text] [Related]
35. Kinetics of 11C-labeled opiates in the brain of rhesus monkeys.
Hartvig P; Bergström K; Lindberg B; Lundberg PO; Lundqvist H; Långström B; Svärd H; Rane A
J Pharmacol Exp Ther; 1984 Jul; 230(1):250-5. PubMed ID: 6611397
[TBL] [Abstract][Full Text] [Related]
36. Acetyl-L-carnitine permeability across the blood-brain barrier and involvement of carnitine transporter OCTN2.
Inano A; Sai Y; Nikaido H; Hasimoto N; Asano M; Tsuji A; Tamai I
Biopharm Drug Dispos; 2003 Nov; 24(8):357-65. PubMed ID: 14595704
[TBL] [Abstract][Full Text] [Related]
37. Carbon-11-d-threo-methylphenidate binding to dopamine transporter in baboon brain.
Ding YS; Fowler JS; Volkow ND; Logan J; Gatley SJ; Sugano Y
J Nucl Med; 1995 Dec; 36(12):2298-305. PubMed ID: 8523123
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of IV and oral acetyl-L-carnitine in a multiple dose regimen in patients with senile dementia of Alzheimer type.
Parnetti L; Gaiti A; Mecocci P; Cadini D; Senin U
Eur J Clin Pharmacol; 1992; 42(1):89-93. PubMed ID: 1541322
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of oral acetyl-L-carnitine in renal impairment.
Kelly JG; Hunt S; Doyle GD; Laher MS; Carmody M; Marzo A; Arrigoni Martelli E
Eur J Clin Pharmacol; 1990; 38(3):309-12. PubMed ID: 2340852
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
